From JAMA: Health Outcomes for post-meno, hysterectomized women on Premarin
http://jama.ama-assn.org/content/305/13/1305.full
"Conclusions. Among postmenopausal women with prior hysterectomy followed up for 10.7 years, CEE use for a median of 5.9 years was not associated with an increased or decreased risk of CHD, deep vein thrombosis, stroke, hip fracture, colorectal cancer, or total mortality. A decreased risk of breast cancer persisted." Hopeful |
All times are GMT -7. The time now is 04:41 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021